Nuvation Bio Ownership | Who Owns Nuvation Bio?
Nuvation Bio Ownership Summary
Nuvation Bio is owned by 67.49% institutional investors, 18.44% insiders, and 14.06% retail investors. Fmr is the largest institutional shareholder, holding 15.04% of NUVB shares.
NUVB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nuvation Bio | 67.49% | 18.44% | 14.06% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 52.23M | 15.04% | $296.67M |
| Blackrock funding, inc. /de | 27.63M | 7.96% | $156.94M |
| Decheng capital | 25.95M | 7.47% | $147.42M |
| Blackrock | 16.24M | 7.41% | $47.41M |
| Vanguard group | 15.56M | 4.54% | $139.38M |
| Vanguard capital management | 11.92M | 3.43% | $67.70M |
| Omega fund management | 8.08M | 2.33% | $45.90M |
| Laurion capital management lp | 7.82M | 2.25% | $44.42M |
| State street | 7.37M | 2.12% | $41.87M |
| Geode capital management | 6.24M | 1.80% | $35.48M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Omega fund management | 8.08M | 24.72% | $45.90M |
| Decheng capital | 25.95M | 20.15% | $147.42M |
| Knoll capital management | 1.60M | 5.06% | $9.08M |
| Tanaka capital management | 685.11K | 4.56% | $2.54M |
| Edbi pte | 1.27M | 3.58% | $3.38M |
| Act capital management | 520.00K | 1.93% | $2.95M |
| Octagon capital advisors lp | 2.63M | 1.48% | $9.74M |
| Redmile group | 3.03M | 1.16% | $17.22M |
| Laurion capital management lp | 7.82M | 1.14% | $44.42M |
| Ghost tree capital | 1.15M | 1.05% | $3.36M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 16.24M | 0.00% | 3.71M |
| Blackrock funding, inc. /de | 27.63M | 0.00% | 2.53M |
| Hrt financial lp | 2.21M | 0.02% | 2.21M |
| Sixth street partners management company | 2.06M | 0.00% | 2.06M |
| American century companies | 4.50M | 0.01% | 1.60M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | - | - | -19.21M |
| Octagon capital advisors lp | 2.63M | 1.48% | -5.06M |
| Bioimpact capital | - | - | -4.62M |
| Aisling capital management lp | - | - | -2.96M |
| Rosalind advisors | - | - | -2.45M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Hrt financial lp | 2.21M | 0.02% | 2.21M | $12.54M |
| Sixth street partners management company | 2.06M | 0.00% | 2.06M | $11.69M |
| First trust advisors lp | 1.30M | 0.00% | 1.30M | $7.40M |
| Ghost tree capital | 1.15M | 1.05% | 1.15M | $3.36M |
| Tanaka capital management | 685.11K | 4.56% | 685.11K | $2.54M |
Sold Out
| Holder | Change |
|---|---|
| Wealth preservation advisors | -15.00 |
| Nelson, van denburg & campbell wealth management group | -28.00 |
| Bare financial services | -53.00 |
| Parkside financial bank & trust | -80.00 |
| Heartwood wealth advisors | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 248 | 4.64% | 234,422,046 | 6.31% | 67 | 1.67% | 152 | 10.14% | 51 | -12.07% |
| Mar 31, 2026 | 235 | 3.07% | 220,513,894 | 4.35% | 64 | 1.70% | 136 | 5.43% | 58 | -13.43% |
| Dec 31, 2025 | 96 | -54.07% | 35,002,980 | -84.13% | 10 | 0.24% | 53 | -57.60% | 28 | -40.43% |
| Sep 30, 2025 | 76 | -56.82% | 27,947,807 | -87.00% | 8 | 0.21% | 42 | -64.71% | 17 | -39.29% |
| Jun 30, 2025 | 184 | 14.29% | 224,710,788 | 8.38% | 65 | 1.76% | 122 | 64.86% | 30 | -42.31% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 19, 2026 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sell | $709.24K |
| Jun 23, 2026 | Markel Stacy | CHIEF PEOPLE OFFICER | Sell | $753.19K |
| Jun 23, 2026 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Sell | $379.19K |
| Jun 23, 2026 | Sauvage Philippe | Chief Financial Officer | Sell | $286.37K |
| Jun 09, 2026 | Mashal Robert | - | Buy | $118.25K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 1 |
| 2026 Q2 | 1 | 6 |
| 2026 Q1 | - | - |
| 2025 Q4 | - | 9 |
| 2025 Q3 | - | - |
NUVB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools